B042843 Phase III Study of Atezolozumab vs Placebo in Patients with High Risk Muscle Invasive Bladder Cancer who are CTDNA positive following Cystectomy
Clinical Trial Grant
Administered By
Urology
Awarded By
Genentech, Inc.
Start Date
September 11, 2023
End Date
September 12, 2029
Administered By
Urology
Awarded By
Genentech, Inc.
Start Date
September 11, 2023
End Date
September 12, 2029